ASLAN Pharmaceuticals Limited in its special shareholders meeting held on October 30, 2018, announced the resignation of Mei-Shu Lai from its Remuneration committee and Audit committee. The board also announced the appointment of Robert E. Hoffman, Independent Director of ASLAN Pharmaceuticals Limited to its Audit committee. The effective date is November 7, 2018.